BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32902876)

  • 1. The risk of unintentional propagation of poliovirus can be minimized by using human cell lines lacking the functional CD155 gene.
    Koike S
    Microbiol Immunol; 2020 Dec; 64(12):835-839. PubMed ID: 32902876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple pathways for establishment of poliovirus infection.
    Arita M; Ohka S; Sasaki Y; Nomoto A
    Virus Res; 1999 Aug; 62(2):97-105. PubMed ID: 10507320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation.
    Khan S; Toyoda H; Linehan M; Iwasaki A; Nomoto A; Bernhardt G; Cello J; Wimmer E
    J Gen Virol; 2014 Aug; 95(Pt 8):1668-1676. PubMed ID: 24784416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor.
    Ohka S; Igarashi H; Nagata N; Sakai M; Koike S; Nochi T; Kiyono H; Nomoto A
    J Virol; 2007 Aug; 81(15):7902-12. PubMed ID: 17507470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poliovirus nonpermissive CD155 knockout cells derived from RD cell line for handling poliovirus potentially infectious materials in virology laboratories.
    Nandi SS; Sawant S; Gohil T; Lambe U; Sangal L; Patel D; Krishnasamy K; Ghoshal U; Harvey P; Deshpande J
    J Med Virol; 2022 Oct; 94(10):4901-4909. PubMed ID: 35642597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome.
    Ohka S; Matsuda N; Tohyama K; Oda T; Morikawa M; Kuge S; Nomoto A
    J Virol; 2004 Jul; 78(13):7186-98. PubMed ID: 15194795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus.
    Pavio N; Couderc T; Girard S; Sgro JY; Blondel B; Colbère-Garapin F
    Virology; 2000 Sep; 274(2):331-42. PubMed ID: 10964776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of poliovirus neurovirulence.
    Ohka S; Nomoto A
    Dev Biol (Basel); 2001; 105():51-8. PubMed ID: 11763337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexes of poliovirus serotypes with their common cellular receptor, CD155.
    He Y; Mueller S; Chipman PR; Bator CM; Peng X; Bowman VD; Mukhopadhyay S; Wimmer E; Kuhn RJ; Rossmann MG
    J Virol; 2003 Apr; 77(8):4827-35. PubMed ID: 12663789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication.
    Jiang P; Faase JA; Toyoda H; Paul A; Wimmer E; Gorbalenya AE
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9457-62. PubMed ID: 17517601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliovirus-nonsusceptible Vero cell line for the World Health Organization global action plan.
    Okemoto-Nakamura Y; Someya K; Yamaji T; Saito K; Takeda M; Hanada K
    Sci Rep; 2021 Mar; 11(1):6746. PubMed ID: 33762624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic cells from CD155-transgenic mice express CD155 and support poliovirus replication ex vivo.
    Freistadt MS; Eberle KE
    Microb Pathog; 2000 Oct; 29(4):203-12. PubMed ID: 10993739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity.
    Mueller S; Papamichail D; Coleman JR; Skiena S; Wimmer E
    J Virol; 2006 Oct; 80(19):9687-96. PubMed ID: 16973573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection.
    Iwasaki A; Welker R; Mueller S; Linehan M; Nomoto A; Wimmer E
    J Infect Dis; 2002 Sep; 186(5):585-92. PubMed ID: 12195344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One hundred years of poliovirus pathogenesis.
    Racaniello VR
    Virology; 2006 Jan; 344(1):9-16. PubMed ID: 16364730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of poliovirus receptor, CD155 expression in different human colorectal cancer cell lines: Implications for poliovirus virotherapy.
    Zhand S; Hosseini SM; Tabarraei A; Moradi A; Saeidi M
    J Cancer Res Ther; 2019; 15(1):61-67. PubMed ID: 30880756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced apoptosis in human intestinal cells cured of persistent poliovirus infection.
    Labadie K; Saulnier A; Martin-Latil S; Colbère-Garapin F
    J Virol; 2007 Mar; 81(6):3033-6. PubMed ID: 17192301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the poliovirus receptor CD155 with the dynein light chain Tctex-1 and its implication for poliovirus pathogenesis.
    Mueller S; Cao X; Welker R; Wimmer E
    J Biol Chem; 2002 Mar; 277(10):7897-904. PubMed ID: 11751937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poliovirus receptor CD155-targeted oncolysis of glioma.
    Merrill MK; Bernhardt G; Sampson JH; Wikstrand CJ; Bigner DD; Gromeier M
    Neuro Oncol; 2004 Jul; 6(3):208-17. PubMed ID: 15279713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Will the polio niche remain vacant?
    Rieder E; Gorbalenya AE; Xiao C; He Y; Baker TS; Kuhn RJ; Rossmann MG; Wimmer E
    Dev Biol (Basel); 2001; 105():111-22; discussion 149-50. PubMed ID: 11763320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.